Live Quote · NASDAQVRCAHealthcare· Biotechnology

Verrica Pharmaceuticals Inc.

$2.74▼ 5.03%($-0.14)
MKT CAP $47.07MNEXT EARNINGS Mar 10, 2027
50%
Bullish
TickerSpark Score
63/100
▌ Mixed
67
Valuation
60
Profitability
100
Growth
60
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRCA research report →

Analyst Price Target
$9.00+228.5% vs. today

Range $9 – $9

Analyst RatingBuy
6 Buy4 Hold0 Sell

Price Chart

-31.84% · this period
$9.10$5.92$2.74Nov 20May 26Nov 20
52-Week Range0% of range
Low
$2.73
Current
$2.74
High
$9.82